Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02332850 |
| Title | SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | University of California, San Francisco |
| Indications | |
| Therapies | |
| Age Groups: | adult | child |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94143 | United States | Details | |
| Colorado Blood Cancer Institute | Denver | Colorado | 80218 | United States | Details | |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | United States | Details | |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | United States | Details | |
| Sarah Cannon Cancer Center | Nashville | Tennessee | 37203 | United States | Details | |
| Princess Margaret Cancer Centre | Toronto | Ontario | M5G 2C1 | Canada | Details |